We have located links that may give you full text access.
Effect of aesthetic rhinoplasty on respiratory functions.
Aesthetic Plastic Surgery 2001 May
Joseph's rhinoplasty operation, with minor modifications, was performed on 20 patients for aesthetic reasons. Various tests of the patient breathing though the nose were carried out both in the preoperative period and 10, 30, and 90 days after surgery. Respiratory-function test results improved in the majority of patients after rhinoplasty. FVC increased in 65% of the cases at day 10, in 85% at day 30, and in 75% at day 90. FEV1 increased in 65% of the cases at day 10, in 65% at day 30, and in 70% at day 90. FEV1/FVC increased in 60% of the cases at day 10, in 65% at day 30, and in 70% at day 90. The only statistically significant increase when compared with preoperative values was the increase in the values of FEV1/FVC at the 30th postoperative day. Decreases in respiratory function test values were insignificant in most of the patients. FEV1/FVC x 100 decreases of more than 10% were seen in three patients, indicating increased nasal resistance, at the 90th postoperative day. However, the lowest value was 50.4 and none of the patients reported subjective nasal obstruction. In conclusion it was observed in this study that properly executed cosmetic rhinoplasty did not have any significant negative effects on respiratory functions in most patients, and improved respiratory functions in most.
Full text links
Related Resources
Trending Papers
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Anti-Arrhythmic Effects of Heart Failure Guideline-Directed Medical Therapy and Their Role in the Prevention of Sudden Cardiac Death: From Beta-Blockers to Sodium-Glucose Cotransporter 2 Inhibitors and Beyond.Journal of Clinical Medicine 2024 Februrary 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app